0
Free At-Home Tests for All Act
12/30/2022, 3:33 AM
Summary of Bill HR 6377
Under this legislation, the government would allocate funding to cover the costs of at-home COVID-19 tests for all individuals, regardless of their insurance status. This would make testing more accessible to those who may not have the means to pay for tests out of pocket.
The bill also includes provisions to ensure that the tests provided are accurate and reliable. It calls for the tests to be approved by the Food and Drug Administration (FDA) and meet certain quality standards. Supporters of the Free At-Home Tests for All Act argue that widespread testing is crucial in controlling the spread of COVID-19 and preventing outbreaks. By providing free at-home tests, the government can help individuals identify and isolate cases of the virus more quickly, ultimately reducing transmission rates. Opponents of the bill may argue that the cost of providing free at-home tests to all Americans could be prohibitive and strain government resources. They may also raise concerns about the accuracy of at-home tests and the potential for false positives or negatives. Overall, the Free At-Home Tests for All Act is a proposed piece of legislation that aims to increase access to COVID-19 testing for all Americans. It seeks to address the ongoing public health crisis and help control the spread of the virus.
Congressional Summary of HR 6377
Free At-Home Tests for All Act
This bill requires the Department of Health and Human Services (HHS) to provide free antigen diagnostic tests for COVID-19 (i.e., rapid tests) to U.S. residents. The bill also automatically grants emergency use authorization for rapid tests approved by certain foreign regulators.
Specifically, HHS must purchase a sufficient quantity of rapid tests to provide two tests per week at no cost to each resident for the 12 months following the bill's enactment. The President may use authorities available under the Defense Production Act of 1950 to obtain the tests. That act confers upon the President a broad set of authorities to influence domestic industry in order to provide essential materials and goods needed for the national defense.
In addition, HHS must conduct outreach about the availability of free rapid tests to Medicare and Medicaid participants and make the tests available through those programs.
The bill also automatically grants emergency use authorization during the public health emergency for rapid tests that are listed for emergency use by (1) the World Health Organization (WHO), or (2) a foreign regulator that is a stringent regulatory authority as defined by the WHO for purposes of medicine procurement. The Food and Drug Administration (FDA) may rescind authority for, or otherwise regulate, a rapid test that was automatically authorized.
Additionally, the FDA must establish a permanent advisory committee focused on diagnostic and serological testing for public health needs.
